AstraZeneca Seeks Emergency Nod In US For AZD7442 To Prevent Symptomatic COVID-19
5/10 09:03
(RTTNews) - AstraZeneca Plc. (AZN) said Tuesday that it has submitted a request to the US Food and Drug Administration for an Emergency Use Authorization for its long-acting antibody combination, AZD7442, for prevention of symptomatic COVID-19....